Veritas Pharma Announces Granting of Stock Options

VANCOUVER, British Columbia, April 27th, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that it has issued 1,215,789 options to directors and officers of the Company under the stock option...

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!